Kobayashi Pharmaceutical Current Debt
| KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Kobayashi Pharmaceutical holds a debt-to-equity ratio of 0.003. . Kobayashi Pharmaceutical's financial risk is the risk to Kobayashi Pharmaceutical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Kobayashi Pharmaceutical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Kobayashi Pharmaceutical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Kobayashi Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Kobayashi Pharmaceutical's stakeholders.
For most companies, including Kobayashi Pharmaceutical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Kobayashi Pharmaceutical Co, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Kobayashi Pharmaceutical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Kobayashi Pharmaceutical's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Kobayashi Pharmaceutical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Kobayashi Pharmaceutical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Kobayashi Pharmaceutical is said to be less leveraged. If creditors hold a majority of Kobayashi Pharmaceutical's assets, the Company is said to be highly leveraged.
Kobayashi |
Kobayashi Pharmaceutical Debt to Cash Allocation
Many companies such as Kobayashi Pharmaceutical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Kobayashi Pharmaceutical Co has accumulated 596 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Kobayashi Pharmaceutical has a current ratio of 3.84, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Kobayashi Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Kobayashi Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kobayashi Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kobayashi to invest in growth at high rates of return. When we think about Kobayashi Pharmaceutical's use of debt, we should always consider it together with cash and equity.Kobayashi Pharmaceutical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Kobayashi Pharmaceutical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Kobayashi Pharmaceutical, which in turn will lower the firm's financial flexibility.Understaning Kobayashi Pharmaceutical Use of Financial Leverage
Kobayashi Pharmaceutical's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Kobayashi Pharmaceutical's total debt position, including all outstanding debt obligations, and compares it with Kobayashi Pharmaceutical's equity. Financial leverage can amplify the potential profits to Kobayashi Pharmaceutical's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Kobayashi Pharmaceutical is unable to cover its debt costs.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.